Page 50 - ARNM-1-2

Advances in Radiotherapy
& Nuclear Medicine SUVmax relating to patient and tumor factors

ovarian cancer via SUVmax value. Jpn J Radiol, 36: 544–550. https://doi.org/10.1200/JCO.2005.06.129
https://doi.org/10.1007/s11604-018-0755-y 17. Downey RJ, Akhurst T, Gonen M, et al., 2007, Fluorine-18
11. Shijun Z, Ning W, Rong Z, et al., 2013, Relationship between fluorodeoxyglucose positron emission tomographic
SUVmax of 18FDG PET and clinicopathological features of maximal standardized uptake value predicts survival
nonsmall cell lung cancer. Chin J Oncol, 35: 754–757. independent of clinical but not pathologic TNM staging
of resected non-small cell lung cancer. J Thorac Cardiovasc
12. Nakamura K, Kodama J, Okumura Y, et al., 2010, The Surg, 133: 1419–1127.
SUVmax of FFDG PET correlates with histological grade
18
in endometrial cancer. Int J Gynecol Cancer, 20: 110–115. https://doi.org/0.1016/j.jtcvs.2007.01.041
https://doi.org/10.1111/IGC.0b013e3181c3a288 18. Kwon W, Howard BA, Herndon JE, et al., 2015, FDG uptake
on positron emission tomography correlates with survival
13. Kitajima K, Kita M, Suzuki K, et al., 2012, Prognostic and time to recurrence in patients with stage I non-small-
significance of SUVmax (maximum standardized uptake cell lung cancer. J Thorac Oncol, 10: 897–902.
value) measured by [18F] FDG PET/CT in endometrial
cancer. Eur J Nucl Med Mol Imaging, 39: 840–845. https://doi.org/10.1097/JTO.0000000000000534
https://doi.org/10.1007/s00259-011-2057-9 19. Agarwal M, Brahmanday G, Bajaj SK, et al., 2010, Revisiting
the prognostic value of preoperative 18F-fluoro-2-
14. Dylan J, Hazem A, David G, et al., 2013, Histological grade/ deoxyglucose ( F-FDG) positron emission tomography
18
differentiation and FFDG PET/CT in oesophageal cancer. (PET) in early-stage (I and II) non-small cell lung cancers
18
Gastroenterol, 144: S515–S519.
(NSCLC). Eur J Nucl Med Mol Imaging, 37: 691–698.
15. Chen Q, Xue Zhen M, 2009, Relationship between https://doi.org/10.1007/s00259-009-1291-x
uptake values of FFDG PET/CT standard and NSCLC
18
clinicopathological factors. J Qilu Med, 24: 104–105. 20. Hoang JK, Hoagland LF, Coleman RE, et al., 2008, Prognostic
value of fluorine-18 fluorodeoxyglucose positron emission
16. Sasaki R, Komaki R, Macapinlac H, et al., 2005, [18F]
fluorodeoxyglucose uptake by positron emission tomography imaging in patients with advanced-stage non-
tomography predicts outcome of non-small-cell lung cancer. small-cell lung carcinoma. J Clin Oncol, 26: 1459–1464.
J Clin Oncol, 23: 1136–1143. https://doi.org/10.1200/JCO.2007.14.3628

Volume 1 Issue 2 (2024) 8 https://doi.org/10.36922/arnm.2032